Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

KORU Medical Systems (KRMD) Research & Development (2020 - 2025)

KORU Medical Systems (KRMD) has disclosed Research & Development for 11 consecutive years, with $933107.0 as the latest value for Q3 2025.

  • On a quarterly basis, Research & Development fell 39.17% to $933107.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $4.4 million, a 19.78% decrease, with the full-year FY2024 number at $5.3 million, down 8.43% from a year prior.
  • Research & Development was $933107.0 for Q3 2025 at KORU Medical Systems, down from $1.2 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.6 million in Q4 2022 to a low of $336841.0 in Q1 2021.
  • A 5-year average of $1.1 million and a median of $1.1 million in 2022 define the central range for Research & Development.
  • Peak YoY movement for Research & Development: soared 240.92% in 2022, then crashed 39.17% in 2025.
  • KORU Medical Systems' Research & Development stood at $949930.0 in 2021, then skyrocketed by 72.85% to $1.6 million in 2022, then fell by 21.59% to $1.3 million in 2023, then decreased by 13.46% to $1.1 million in 2024, then decreased by 16.25% to $933107.0 in 2025.
  • Per Business Quant, the three most recent readings for KRMD's Research & Development are $933107.0 (Q3 2025), $1.2 million (Q2 2025), and $1.1 million (Q1 2025).